Cancer history and risk factors in healthy older people enrolling in the ASPREE clinical trial
Authors:
- Suzanne G. OrchardSuzanne G. Orchard
- Jessica E. LockeryJLJessica E. Lockery
- Peter GibbsPGPeter Gibbs
- Galina PolekhinaGPGalina Polekhina
- Rory WolfeRWRory Wolfe
- John ZalcbergJZJohn Zalcberg
- Andrew HaydonAHAndrew Haydon
- John J. McNeilJMJohn J. McNeil
- Mark R. NelsonMNMark R. Nelson
- Christopher M. ReidCRChristopher M. Reid
- Brenda KirpachBKBrenda Kirpach
- Anne M. MurrayAMAnne M. Murray
- 31 July 2020
- journal article
- research article
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 96, 106095
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- National Health and Medical Research Council
- Foundation for the National Institutes of Health
This publication has 42 references indexed in Scilit:
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trialsThe Lancet, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2011
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- The global burden of cancer: priorities for preventionCarcinogenesis, 2009
- Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer riskInternational Journal of Epidemiology, 2009
- Total Exposure and Exposure Rate Effects for Alcohol and Smoking and Risk of Head and Neck Cancer: A Pooled Analysis of Case-Control StudiesAmerican Journal of Epidemiology, 2009
- Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysisThe Lancet Oncology, 2008
- Physical Activity and Survival After Breast Cancer DiagnosisJAMA, 2005
- Inflammation and cancerNature, 2002